Plasma levels of 15-keto-13,14-dihydro-prostaglandin E2 in patients with bronchogenic carcinoma
- 1 March 1984
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes and Medicine
- Vol. 13 (3) , 249-258
- https://doi.org/10.1016/0262-1746(84)90037-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A sensitive radioimmunoassay for 11-deoxy-13,14-d i h yd ro-15-k eto-11,16-cycloprostaglandin E2: Application as an index of prostaglandin E2 biosynthesis during human pregnancy and parturitionProstaglandins, Leukotrienes and Medicine, 1982
- Antibodies against dehydration products of 15-keto-13,14-dihydro-prostaglandin E2FEBS Letters, 1980
- Captopril-induced Changes in Prostaglandin ProductionJournal of Clinical Investigation, 1980
- PROSTAGLANDINS AND BREAST CANCERThe Lancet, 1977
- Hypercalcemia and tumor-prostaglandins: The VX2 carcinoma model in the rabbitMetabolism, 1975
- ProstaglandinsAnnual Review of Biochemistry, 1975
- Endogenous levels of 15-keto-dihydro-prostaglandins in human plasma: Parameters for monitoring prostaglandin synthesisBiochemical Medicine, 1974
- EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2The Journal of Experimental Medicine, 1972
- Prostaglandins: Their Disappearance from and Release into the CirculationNature, 1967
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948